4.5. Analysis.

Comparison 4 ICS versus placebo, cross‐over studies, 2 months or less (all doses), Outcome 5 Change in post‐bronchodilator FEV1.

Comparison 4 ICS versus placebo, cross‐over studies, 2 months or less (all doses), Outcome 5 Change in post‐bronchodilator FEV1.